Clinical trial
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
NCT00054951 · FeRx, Industry · Unknown status
Key facts
| NCT number | NCT00054951 |
|---|---|
| Title | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads |
| Official title | A Phase I/II, Open Label, Multicenter, Single-Arm, Safety and Efficacy Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery (Via Hepatic Artery Catheterization) for the Treatment of Patients With Unresectable Hepatocellular… |
| Lead sponsor | FeRx, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | MTC-DOX for Injection |
| Enrollment | 30 |
| Start date | Jun 1, 2001 |
| First posted | Feb 17, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: